Tranexamic Acid Use in Prehospital Uncontrolled Hemorrhage

Pfizer, 2016, Cyklokapron (tranexamic acid) injection package insert Xanodyne Pharmaceuticals I. Lysteda (tranexamic acid) tablets package insert, revised 2016. Available at: www.lysteda.com. Accessed July 13, 2016. Henry, 2007, Anti-fibrinolytic use for minimising perioperative allogenic blood transfusion, Cochrane Database Syst Rev., CD001886 2010, Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial, Lancet., 376, 23, 10.1016/S0140-6736(10)60835-5 Morrison, 2012, Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study, Arch Surg., 147, 113, 10.1001/archsurg.2011.287 2011, The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial, Lancet., 1096 2014 Kashuk, 2010, Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma, Ann Surg., 252, 434, 10.1097/SLA.0b013e3181f09191 1994, Fresh-Frozen Plasma, Cryoprecipitate, Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists, JAMA., 271, 777, 10.1001/jama.1994.03510340067036 Gonzalez, 2016, Goal-directed hemostatic resuscitation of trauma-induced coagulopathy, Ann Surg., 263, 1051, 10.1097/SLA.0000000000001608 Cohen, 2013, Clinical and mechanistic drivers of acute traumatic coagulopathy, J Trauma Acute Care Surg., 75, S40, 10.1097/TA.0b013e31828fa43d Mitra, 2011, Early prediction of acute traumatic coagulopathy, Resuscitation., 82, 1208, 10.1016/j.resuscitation.2011.04.007 Hoffman, 2001, A cell based model of hemostasis, Thromb Haemost., 85, 958, 10.1055/s-0037-1615947 Dunbar, 2009, Thrombin generation in trauma patients, Transfusion., 49, 2652, 10.1111/j.1537-2995.2009.02335.x Brohi, 2007, Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?, Ann Surg., 245, 812, 10.1097/01.sla.0000256862.79374.31 Fergusson, 2008, A comparison of aprotinin and lysine analogues in high-risk cardiac surgery, N Engl J Med., 358, 2319, 10.1056/NEJMoa0802395 Murkin, 2010, High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients, Anesth Analg., 110, 350, 10.1213/ANE.0b013e3181c92b23 Martin, 2008, The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients, Anesth Analg., 17, 1783, 10.1213/ane.0b013e318184bc20 Vermylen, 1968, A double blind study of the effect of tranexamic acid in essential menorrhagia, Bull Soc R Belge Gynecol Obstet., 13, 158 Lethaby, 2000, Antifibrinolytics for heavy menstrual bleeding, Cochrane Database Syst Rev., CD000249 Cormack, 1973, Tranexamic acid in upper gastrointestinal hemorrhage, Lancet., 1, 1207, 10.1016/S0140-6736(73)90525-4 Tavenner, 1972, Use of tranexamic acid in control of haemorrhage after extraction of teeth in haemophilia and Christmas disease, BMJ., 2, 314, 10.1136/bmj.2.5809.314 Hardy, 1992, Natural and synthetic antifibrinolytics in cardiac surgery, Can J Anaesth., 39, 353, 10.1007/BF03009046 Sander, 2010, Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis, Critical Care., 14, R148, 10.1186/cc9216 Martin, 2011, Seizures after open heart surgery: comparison of epsilon-aminocaproic acid and tranexamic acid, J Cardiothorac Vasc Anesth., 25, 20, 10.1053/j.jvca.2010.10.007 Kagoma, 2009, Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials, Thrombosis Res., 123, 687, 10.1016/j.thromres.2008.09.015 Poeran, 2014, Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: a retrospective analysis of effectiveness and safety, BMJ., 349, g4829, 10.1136/bmj.g4829 Ker, 2012, Effect of tranexamic acid on surgical bleeding: a systematic review and cumulative meta-analysis, BMJ., 344, e3054, 10.1136/bmj.e3054 Perel, 2013, Tranexamic acid for reducing mortality in emergency and urgent surgery, Cochrane Database Syst Rev., CD010245 Kragh, 2009, Survival with emergency tourniquet use to stop bleeding in major limb trauma, Ann Surg., 249, 1, 10.1097/SLA.0b013e31818842ba Cotton, 2012, Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration, J Trauma Acute Care Surg., 73, 365, 10.1097/TA.0b013e31825c1234 Chapman, 2013, Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy, J Trauma Acute Care Surg., 75, 961, 10.1097/TA.0b013e3182aa9c9f Holcomb, 2012, Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients, Ann Surg., 256, 476, 10.1097/SLA.0b013e3182658180 Kutcher, 2012, Criteria for empiric treatment of hyperfibrinolysis after trauma, J Trauma Acute Care Surg., 73, 87, 10.1097/TA.0b013e3182598c70 Ives, 2012, Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma, J Am Coll Surg., 215, 496, 10.1016/j.jamcollsurg.2012.06.005 Wafaisade, 2016, Prehospital administration of tranexamic acid in trauma patients, Critical Care., 20, 143, 10.1186/s13054-016-1322-5 Swendsen, 2013, Tranexamic acid use in trauma: effective but not without consequences, J Trauma Treat., 2, 179 Valle, 2014, Do all trauma patients benefit from tranexamic acid?, J Trauma Acute Care Surg., 76, 1373, 10.1097/TA.0000000000000242 Harvin, 2015, The impact of tranexamic acid on mortality in injured patients with hyperfibrinolysis, J Trauma Acute Care Surg., 78, 905, 10.1097/TA.0000000000000612 Cole, 2015, Tranexamic acid use in severely injured civilian patients and the effects on outcomes: a prospective cohort study, Ann Surg., 261, 390, 10.1097/SLA.0000000000000717 Schouten, 2009, The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis, Pediatr Crit Care Med., 10, 182, 10.1097/PCC.0b013e3181956d61 Eckert, 2014, Tranexamic acid administration to pediatric trauma patients in a combat setting: the pediatric trauma and tranexamic acid study (PED-TRAX), J Trauma Acute Care Surg., 77, 852, 10.1097/TA.0000000000000443 Cap, 2011, Tranexamic acid for trauma patients: a critical review of the literature, J Trauma., 71, S9 Napolitano, 2013, Tranexamic acid in trauma: how should we use it?, J Trauma Acute Care Surg., 74, 1575, 10.1097/TA.0b013e318292cc54 Pusateri, 2013, Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities, Shock., 39, 121, 10.1097/SHK.0b013e318280409a Moore, 2015, Postinjury fibrinolysis shutdown: rationale for selective tranexamic acid, J Trauma Acute Care Surg., 78, S65, 10.1097/TA.0000000000000634 Moore, 2014, Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy, J Trauma Acute Care Surg., 77, 811, 10.1097/TA.0000000000000341 Heier, 2015, Use of tranexamic acid in bleeding combat casualties, Mil Med., 180, 844, 10.7205/MILMED-D-14-00592 Jimenez, 2011, Safety and effectiveness of two treatment regimens with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial, J Cardiothorac Surg., 6, 138, 10.1186/1749-8090-6-138 Reichel, 2011, Plasmin inhibitors prevent leukocyte accumulation and remodeling events in postischemic microvasculature, PLoS ONE., 6, e17229, 10.1371/journal.pone.0017229 Peng, 2016, Intraluminal tranexamic acid inhibits intestinal sheddases and mitigates gut and lung injury and inflammation in a rodent model of hemorrhagic shock, J Trauma Acute Care Surg., 81, 358, 10.1097/TA.0000000000001056 Johansson, 2011, A high syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients, Ann Surg., 254, 194, 10.1097/SLA.0b013e318226113d Mitra, 2014, Tranexamic acid for trauma: filling the ‘GAP’ in evidence, Emerg Med Australas., 26, 194, 10.1111/1742-6723.12172 Bernard S, Mitra B, Gruen R, et al. PATCH-Trauma Study. Available at: https://www.patchtrauma.org/. Accessed July 17, 2016. Gruen, R. Pre-hospital anti-fibrinolytics for traumatic coagulopathy and haemorrhage (the PATCH study). Available at: https://clinicaltrials.gov/ct2/show/NCT02187120?term=NCT02187120&rank=1. Accessed July 19, 2016. Brown, 2015, Design of the study of tranexamic acid during air medical prehospital transport (STAAMP) trial: addressing the knowledge gaps, Prehosp Emerg Care., 19, 79, 10.3109/10903127.2014.936635 Brown JB, Neal MD, Guyette FX, et al. Study of tranexamic acid during air medical prehospital transport (STAAMP) trial. Available at: https://clinicaltrials.gov/ct2/show/NCT02086500?term=STAAMP&rank=1. Accessed July 19, 2016. Spinella P, Bochicchio G. Tranexamic acid mechanisms and pharmacokinetics in traumatic injury (TAMPITI trial). Available at: http://www.tampiti.wustl.edu/. Accessed July 15, 2016. Spinella P, Bochicchio G. Tranexamic acid mechanisms and pharmacokinetics in traumatic injury (TAMPITI trial). Available at: https://clinicaltrials.gov/ct2/show/NCT02535949?term=TAMPITI&rank=1. Accessed July 19, 2016. May S, Schreiber, M. Prehospital tranexamic acid use for traumatic brain injury (TXA). Available at: https://www.clinicaltrials.gov/ct2/show/NCT01990768?term=Prehospital+Tranexamic+Acid+Use+for+Traumatic+Brain+Injury&rank=1. Accessed October 30, 2016.